Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)
Ruth M Tarzi, Charles D PuseyRenal and Vascular Inflammation Section, Department of Medicine, Imperial College, London, UKAbstract: Granulomatosis with polyangiitis (GPA, formerly Wegener's granulomatosis) is a multisystem autoimmune condition associated with anti-neutrophil cytoplasm antibo...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2014-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Ruth M Tarzi, Charles D PuseyRenal and Vascular Inflammation Section, Department of Medicine, Imperial College, London, UKAbstract: Granulomatosis with polyangiitis (GPA, formerly Wegener's granulomatosis) is a multisystem autoimmune condition associated with anti-neutrophil cytoplasm antibodies. Management of GPA can be complex, owing to the sometimes fulminant and multisystem nature of the presentation, the age demographics of the affected population, and a significant incidence of disease relapse. In this paper, we discuss how some of the challenges in the management of GPA have been and continue to be addressed including: reducing the toxicity of induction therapy; developing biomarkers to determine who can safely stop maintenance immunosuppression; improving the efficacy of maintenance therapy for relapsing patients; managing localized disease; and management of disease and treatment-associated comorbidity. Consideration is also given to emerging therapeutics in the treatment of GPA.Keywords: anti-neutrophil cytoplasm antibody, vasculitis, immunosuppression, biologics |
|---|---|
| Item Description: | 1178-203X |